These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16231045)

  • 1. Validation overview of bio-analytical methods.
    Tuomela M; Stanescu I; Krohn K
    Gene Ther; 2005 Oct; 12 Suppl 1():S131-8. PubMed ID: 16231045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of assay validation in specification development.
    Baffi RA
    Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.
    Shankar G; Devanarayan V; Amaravadi L; Barrett YC; Bowsher R; Finco-Kent D; Fiscella M; Gorovits B; Kirschner S; Moxness M; Parish T; Quarmby V; Smith H; Smith W; Zuckerman LA; Koren E
    J Pharm Biomed Anal; 2008 Dec; 48(5):1267-81. PubMed ID: 18993008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy bio-safety: scientific and regulatory issues.
    Gonin P; Buchholz CJ; Pallardy M; Mezzina M
    Gene Ther; 2005 Oct; 12 Suppl 1():S146-52. PubMed ID: 16231047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products.
    Mire-Sluis AR; Barrett YC; Devanarayan V; Koren E; Liu H; Maia M; Parish T; Scott G; Shankar G; Shores E; Swanson SJ; Taniguchi G; Wierda D; Zuckerman LA
    J Immunol Methods; 2004 Jun; 289(1-2):1-16. PubMed ID: 15251407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of assays for use with combination vaccines.
    Klein J; Capen R; Mancinelli R; Robinett R; Pietrobon PJ; Quinn J; Schofield T
    Biologicals; 1999 Mar; 27(1):35-41. PubMed ID: 10441401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of scientific and regulatory issues for the immunogenicity of biological products.
    Chamberlain P; Mire-Sluis AR
    Dev Biol (Basel); 2003; 112():3-11. PubMed ID: 12762499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of standard and state of the art analytical technology-bioassays.
    Indelicato SR; Bradshaw SL; Chapman JW; Weiner SH
    Dev Biol (Basel); 2005; 122():103-14. PubMed ID: 16375255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.
    Gupta S; Indelicato SR; Jethwa V; Kawabata T; Kelley M; Mire-Sluis AR; Richards SM; Rup B; Shores E; Swanson SJ; Wakshull E
    J Immunol Methods; 2007 Apr; 321(1-2):1-18. PubMed ID: 17307199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensuring quality of in vitro alternative test methods: Current practice.
    Rispin A; Stitzel K; Harbell J; Klausner M
    Regul Toxicol Pharmacol; 2006 Jul; 45(2):97-103. PubMed ID: 16644076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioassays for the measurement of neutralizing antibodies in serum (SNFs).
    Indelicato SR
    Dev Biol (Basel); 2003; 112():113-25. PubMed ID: 12762510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial design for adenoviral gene therapy products.
    Shirakawa T
    Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
    Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
    Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of fermentation processes.
    Lubiniecki AS; Gardner AR; Smith TM; Wang WK; McAllister PR; Federici MM
    Dev Biol (Basel); 2003; 113():37-44; discussion 111-2. PubMed ID: 14620850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among product characterization, process validation and preclinical/clinical studies for well-characterized products.
    Lubiniecki AS
    Dev Biol Stand; 1998; 96():173-5; discussion 177-9. PubMed ID: 9890530
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
    Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
    J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.